Skip to main content

Table 2 Reasons for discontinuation of treatment

From: The effectiveness of retreatment with peginterferon alfa and ribavirin in patients with chronic viral hepatitis C genotype 2 and 3: a prospective cohort study in Brazil

Reasons for discontinuation

Number of patients,n (%)

Adverse Events

40 (18.5)

No reduction of 2 log viral load at week 12

3 (1.4)

Positive PCR qualitative at week 24

5 (2.3)

Withdrawal of the patients

3 (1.4)

Total discontinuation of treatment

51 (23.6)